BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 3621117)

  • 1. Nonoperative urinary diversion for malignant ureteral obstruction.
    Zadra JA; Jewett MA; Keresteci AG; Rankin JT; St Louis E; Grey RR; Pereira JJ
    Cancer; 1987 Sep; 60(6):1353-7. PubMed ID: 3621117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
    Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
    BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
    Bell DG; Fischer MA
    Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of full-length metallic stents in malignant ureteral obstruction.
    Abbasi A; Wyre HW; Ogan K
    J Endourol; 2013 May; 27(5):640-5. PubMed ID: 23237309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].
    Netsch C; Becker B; Gross AJ
    Urologe A; 2016 Nov; 55(11):1497-1510. PubMed ID: 27787581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous nephrostomy for palliation of metastatic ureteral obstruction.
    Culkin DJ; Wheeler JS; Marsans RE; Nam SI; Canning JR
    Urology; 1987 Sep; 30(3):229-31. PubMed ID: 2442872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
    Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
    J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer.
    Ekici S; Sahin A; Ozen H
    J Endourol; 2001 Oct; 15(8):827-9. PubMed ID: 11724123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
    Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
    Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tandem Ureteral Stents for Malignant Ureteral Obstruction.
    Haifler M; Shvero A; Zilberman D; Ramon J; Winkler H; Margel D; Kleinmann N
    J Endourol; 2020 Feb; 34(2):222-226. PubMed ID: 31724450
    [No Abstract]   [Full Text] [Related]  

  • 12. Percutaneous nephrostomy for ureteral obstruction in patients with gynecologic malignancy.
    Coddington CC; Thomas JR; Hoskins WJ
    Gynecol Oncol; 1984 Jul; 18(3):339-48. PubMed ID: 6204911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction.
    Gasparini M; Carroll P; Stoller M
    Urology; 1991 Nov; 38(5):408-12. PubMed ID: 1719688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique extra-anatomic urinary diversion!
    Mishra VC; Rao AR; Desai AR; Charig M; Karim OM
    J Endourol; 2004 Feb; 18(1):57-8. PubMed ID: 15006055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous urinary diversion: an alternative to percutaneous nephrostomy.
    Lingam K; Paterson PJ; Lingam MK; Buckley JF; Forrester A
    J Urol; 1994 Jul; 152(1):70-2. PubMed ID: 8201692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
    Kraemer PC; Borre M
    Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Techniques for bypassing and stenting ureteral obstructions.
    Mata JA; Culkin DJ; Venable DD
    J Urol; 1994 Sep; 152(3):917-9. PubMed ID: 8051753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous management of benign ureteral strictures and fistulas.
    Chang R; Marshall FF; Mitchell S
    J Urol; 1987 Jun; 137(6):1126-31. PubMed ID: 3586141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases.
    Heo JE; Jeon DY; Lee J; Ham WS; Choi YD; Jang WS
    Ann Surg Oncol; 2021 Apr; 28(4):2367-2373. PubMed ID: 33389298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydronephrosis in malignant tumors: rationale and efficiency of endo-urological diversions.
    Hübner WA; Plas EG; Porpaczy P
    Eur J Surg Oncol; 1993 Feb; 19(1):27-32. PubMed ID: 8436237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.